Global Intravenous (IV) Therapy and Vein Access Market Is Expected to Reach $37.5 Billion by 2030: AMR
June 23, 2022
Significant surge in the cases of chronic diseases among people, growth in road accidents, increase in healthcare expenditure and healthcare insurance, and increase in geriatric population across the globe are expected to drive the growth of the global intravenous (IV) therapy and vein access market. Based on application, the medication administration segment held the largest market share in 2020.
/EIN News/ -- Portland, OR, June 23, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Intravenous (IV) Therapy And Vein Access Market generated $22.8 billion in 2020, and is projected to reach $37.5 billion by 2030, growing at a CAGR of 5.1% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/2350
Significant surge in the cases of chronic diseases among people, growth in road accidents, increase in healthcare expenditure and healthcare insurance, and increase in geriatric population across the globe are expected to drive the growth of the global intravenous (IV) therapy and vein access market. On the other hand, lack of experienced healthcare professionals is expected to hinder the growth of the market. However, remarkable upsurge in critical care therapies is expected to create ample opportunities for the industry.
- The outbreak of COVID-19 has had a positive impact on the growth of the global intravenous (IV) therapy and vein access market, owing to the rapid increase in the spread of coronavirus among people across the globe. IV therapy was extensively used among patients suffering from severe COVID-19-associated acute respiratory distress syndrome (ARDS).
- Thus, increase in number of patients suffering from COVID-19-associated ARDS subsequently surged the demand for intravenous (IV) therapy and vein access.
The report offers a detailed segmentation on the global intravenous (IV) therapy and vein access market based on type, medical application, end-user and region.
Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/2350
Based on application, the medication administration segment held the largest market share in 2020, garnering more than one-third of the global market. In addition, the same segment is predicted to cite the fastest CAGR of 5.6% during the forecast period. Other segments analyzed in the report include volume expander, blood-based products and nutrition, and buffer solution.
Based on end user, the hospital segment held the majority market share in 2020, holding nearly half of the global market. The clinics segment, on the other hand is expected to exhibit the fastest CAGR of 7.0% during the forecast period.
Based on region, the market across North America held the lion’s share in 2020, garnering around two-fifths of the global market. The Asia-Pacific region, on the other hand, is expected to cite the fastest CAGR of 6.4% during the forecast period.
The key players analyzed in the global intravenous (IV) therapy and vein access market report include Becton, Dickinson & Company, Braun Melsungen AG, Terumo medical corporation, Teleflex Medical Inc., Medtronic Inc., Angiodynamic, Inc.., Smith& Nephew Plc., Pfizer Inc., Insulet Corporation, and Fresenius SE& CO. KGAA.
|Revenue forecast in 2030||USD 37.5 Billion|
|Growth rate||CAGR of 5.1% from 2021 to 2030|
|Forecast period||2022 - 2030|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Regional scope||North America, Europe, Asia Pacific, Latin America, MEA|
|Country scope||U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India, South Korea, Australia, Brazil, Mexico, South Africa, Saudi Arabia|
|Key companies profiled||Becton, Dickinson & Company, Braun Melsungen AG, Terumo medical corporation, Teleflex Medical Inc., Medtronic Inc., Angiodynamic, Inc.., Smith& Nephew Plc., Pfizer Inc., Insulet Corporation, and Fresenius SE& CO. KGAA.|
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 firstname.lastname@example.org Web: https://www.alliedmarketresearch.com/reports-store/life-sciences Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/